Defective lymphocyte caspase-3 expression in type 1 diabetes mellitus

European Journal of Endocrinology

Volumn 152, Issue 1, 2005, Pages 119-125

  Vendrame, Francesco ^b   Santangelo, Carmela ^a   Misasi, Roberta ^b   Dionisi, Sabrina ^b   Gizzi, Chiara ^b   Realacci, Massimo ^b   Grassetti, Daniele ^c   di Mario, Umberto ^b   Dotta, Francesco ^c,d  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; MESSENGER RNA; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CASPASES; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; IMMUNOBLOTTING; LYMPHOCYTE ACTIVATION; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 13244294109     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01813     Document Type: Article

References (24)

1. Miller JF & Flavell RA. T-cell tolerance and autoimmunity in transgenic models of central and peripheral tolerance. Current Opinion in Immunology 1994 6 892-899.
2. Sprent J & Kishimoto H. The thymus and negative selection. Immunology Reviews 2002 185 126-135.
3. Green DR, Droin N & Pinkoski M. Activation-induced cell death in T cells. Immunology Reviews 2003 193 70-81.
4. Budd RC. Activation-induced cell death. Current Opinion in Immunology 2001 13 356-362.
5. Brunner T, Mogil RJ, LaFace D, Yon NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF & Green DR. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995 373 441-444.
6. Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ & Marshak-Rothstein A. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995 373 444-448.
7. Krammer PH. CD95 (Apo-1/Fas)-mediated apoptosis: live and let die. Advances in Immunology 1999 71 163-210.
8. Krammer PH. CD95's deadly mission in the immune system. Nature 2000 407 789-795.
9. Nagata S & Suda T. Fas and Fas ligand: lpr and gld mutations. Immunology Today 1995 16 39-43.
10. 2D3 restores defect. Diabetes 1998 47 1033-1037.
11. Casteels K, Waer M, Bouillon R, Depovere J, Valckx D, Laureys J & Mathieu C. 1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes. Clinical and Experimental Immunology 1998 112 181-187.
12. Colucci F, Bergman ML, Penha-Goncalves C, Cilio CM & Holmberg D. Apoptosis resistance of non-obese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. PNAS 1997 94 8670-8674.
13. Decallonne B, van Etten E, Giulietti A, Casteels K, Overbergh L, Bouillon R & Mathieu C. Defect in activation-induced cell death in non-obese diabetic (NOD) T lymphocytes. Journal of Autoimmunity 2003 20 219-226.
14. Giordano C, De Maria R, Stassi G, Todaro M, Rachiusa P, Giordano M & Galluzzo A. Defective expression of the apoptosis-inducing CD95 (Fas/Apo-1) molecule on T and B cells in T1DM. Diabetologia 1995 38 1449-1454.
15. Stassi G, Todaro M, De Maria R, Candore G, Cigna D, Caruso C, Galluzzo A & Giordano C. Defective expression of CD95 (Fas/Apo-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals. Human Immunology 1997 55 39-45.
16. De Franco S, Bonissoni S, Cerutti F, Bona G, Bottarel F, Cadario F, Brusco A, Loffredo G, Rabbone I, Corrias A, Pignata C, Ramenghi U & Dianzani U. Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases. Diabetes 2001 50 483-488.
17. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F & Riccardi C. A rapid and simple method for measuring thymocytes apoptosis by propidium iodide staining and flow cytometry. Journal of Immunological Methods 1991 139 271-279.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 227 680-685.
19. Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH & Peter ME. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. Journal of Biological Chemistry 1999 274 22532-22538.
20. Aouad SM, Cohen LY, Sharif-Askari E, Haddad EK, Alam A & Sekaly RP. Caspase-3 is a component of Fas death-inducing signaling complex in lipid rafts and its activity is required for complete caspase-8 activation during Fas-mediated cell death. Journal of Immunology 2004 172 2316-2323.
21. Semra YK, Seidi OA & Sharief MK. Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis. Journal of Neuroimmunology 2001 113 268-274.
22. Sharief MK & Semra YK. Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis. Journal of Neuroimmunology 2001 119 358-364.
23. Waase I, Kayser C, Carlson PJ, Goronzy JJ & Weyand CM. Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. Arthritis and Rheumatism 1996 39 904-913.
24. Nagata S. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model. Journal of Human Genetics 1998 43 2-8.